U.S. drug prices continue to soar

Apr. 03, 2019 4:15 AM ETHealth Care Select Sector SPDR (XLV), IYH, VHT, PJP, CURE, HQH, XPH, RXL, FXH, IHE, FHLC, PPH, RYH, THQ, RXDXLV, PPH, IYH, VHT, PJP, IHE, XPH, HQH, RYH, RXD, RXL, FXH, CURE, FHLC, THQBy: Yoel Minkoff, SA News Editor33 Comments
  • Pharmaceutical companies are continuing to defy political pressure from both Democrats and Republicans by raising the prices of almost 3,000 drugs in the U.S. in the first three months of this year.
  • Generic versions of the antidepressant Prozac and the painkiller Vicodin were among the medicines with triple-digit percentage increases.
  • Drug costs continue to increase at four times the rate of inflation, causing concern for employers, health insurers and consumers, said RX Savings Solutions CEO Michael Rea.
  • ETFs: XLV, IYH, VHT, PJP, CURE, HQH, XPH, RXL, FXH, IHE, FHLC, PPH, RYH, THQ, RXD

Recommended For You

Comments (33)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.